Parkinson MedicationsPage 10 of 10

8. References / Quiz Login or Register

Brunton LL, Chabner BA, Knollmann BC. (Eds.). (2011). Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 12 ed. Chapter 22, Treatment of Central Nervous System Degenerative Disorders. New York: McGraw-Hill.

Cook NP, Kilpatrick K, Segatori L, Mart AA. (2012). Detection of α-synuclein amyloidogenic aggregates in vitro and in cells using light-switching dipyridophenazine ruthenium(ii) complexes. Journal of the American Chemical Society 121214074651005 doi:10.1021/ja3100287.

Cummings JL, Henchcliffe C, Schaier S, et al. (2011). The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration. Brain 134(Pt 11):3146–66. doi: 10.1093/brain/awr177. Epub 2011 Aug 2.

Food and Drug Administration (FDA). (2010). Coping with memory loss. Retrieved October 18, 2012 from

Hoehn M, Yahr M . (1967). Parkinsonism: Onset, progression and mortality. Neurology 17(5): 427–42. PMID 6067254.

Huot P, Johnston TH, Koprich JB, et al. (2013). The pharmacology of L-DOPA-induced dyskinesia in Parkinson’s disease. Pharmacol Rev 10;65(1):171–222. doi:10.1124/pr.111.005678.

Kalda A, Yu L, Oztas E, Chen JF. (2006). Novel neuroprotection by caffeine and adenosine A(2A) receptor antagonists in animal models of Parkinson’s disease. J Neurol Sci 248(1-2):9–15.

Kumar KR, Djarmati-Westenberger A, Grünewald A. (2011). Genetics of Parkinson’s disease. Semin Neurol 31(5):433–40. doi: 10.1055/s-0031-1299782. Epub 2012 Jan 21.

Martinez TN, Greenamyre JT. (2012). Toxin models of mitochondrial dysfunction in Parkinson’s disease. Antioxid Redox Signal 16(9):920–34. doi: 10.1089/ars.2011.4033. Epub 2011 Jul 12.

Medline Plus.(2012). Parkinson’s Disease. Retrieved July 29, 2012 from

National Institutes of Health (NIH). (2012). Senior Health. Retrieved December 12, 2012 from

National Institute of Neurological Disorders and Stroke (NINDS). (2012.) Parkinson’s Disease Information Page. Retrieved August 8, 2012 from

Okun MS. (2012). Deep-brain stimulation for Parkinson’s disease. N Engl J Med 367(16):1529–38. doi:10.1056/NEJMct1208070.

Wikipedia. (2012a, August 3). Parkinson’s Disease. Wikimedia Foundation. Retrieved August 3, 2012 from

Wikipedia. (2012b, August 3). History of Parkinson’s Disease. Wikimedia Foundation. Retrieved August 3, 2012 from

You've reached the end of this section